▶ 調査レポート

てんかん監視装置の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Epilepsy Monitoring Devices Market (Product: Conventional Devices and Wearable Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。てんかん監視装置の世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Epilepsy Monitoring Devices Market (Product: Conventional Devices and Wearable Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2210A0079資料のイメージです。• レポートコード:MRC2210A0079
• 出版社/出版日:Transparency Market Research / 2022年7月
• レポート形態:英文、PDF、154ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートでは、世界のてんかん監視装置市場規模について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場見通し、製品別(従来型装置、ウェアラブル型装置)分析、エンドユーザー別(病院・クリニック、在宅医療、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況など、以下の項目を掲載しております。本書では、Koninklijke Philips N.V、Medtronic plc、Compumedics Limited、Natus Medical Incorporated、Empatica,Inc.、PulseGuard International Ltd.、Masimo、Other prominent playersなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・市場見通し

・世界のてんかん監視装置市場規模:製品別
- 従来型てんかん監視装置の市場規模
- ウェアラブル型てんかん監視装置の市場規模

・世界のてんかん監視装置市場規模:エンドユーザー別
- 病院・クリニックにおける市場規模
- 在宅医療における市場規模
- その他エンドユーザーの市場規模

・世界のてんかん監視装置市場規模:地域別
- 北米のてんかん監視装置市場規模
- ヨーロッパのてんかん監視装置市場規模
- アジア太平洋のてんかん監視装置市場規模
- 中南米のてんかん監視装置市場規模
- 中東/アフリカのてんかん監視装置市場規模

・競争状況

Epilepsy Monitoring Devices Market – Scope of Report
TMR’s report on the global epilepsy monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global epilepsy monitoring devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global epilepsy monitoring devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the epilepsy monitoring devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global epilepsy monitoring devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global epilepsy monitoring devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global epilepsy monitoring devices market.

The report delves into the competitive landscape of the global epilepsy monitoring devices market. Key players operating in the global epilepsy monitoring devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global epilepsy monitoring devices market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market epilepsy monitoring devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Epilepsy Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Epilepsy Monitoring Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Product Details/ Providers/ Technological Advancements
5.2. Product Details & Pricing Analysis
5.3. Epidemiology of Epilepsy & Prevalence Data
5.4. Volume Data for epilepsy devices (2021)
5.5. Epilepsy Biomarkers
5.6. Epilepsy Monitoring Devices: Demand/Supply Scenario
6. Global Epilepsy Monitoring Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Conventional Devices
6.3.2. Wearable Devices
6.4. Market Attractiveness Analysis, by Product
7. Global Epilepsy Monitoring Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals & Clinics
7.3.2. Home Care Settings
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Epilepsy Monitoring Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia-Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region/Sub-region
9. North America Epilepsy Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Conventional Devices
9.2.2. Wearable Devices
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Clinics
9.3.2. Home Care Settings
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Epilepsy Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Conventional Devices
10.2.2. Wearable Devices
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals & Clinics
10.3.2. Home Care Settings
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. France
10.4.3. U.K.
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia-Pacific Epilepsy Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Conventional Devices
11.2.2. Wearable Devices
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals & Clinics
11.3.2. Home Care Settings
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Epilepsy Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Conventional Devices
12.2.2. Wearable Devices
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals & Clinics
12.3.2. Home Care Settings
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Epilepsy Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast by Product, 2017–2031
13.2.1. Conventional Devices
13.2.2. Wearable Devices
13.3. Market Value Forecast by End-user, 2017–2031
13.3.1. Hospitals & Clinics
13.3.2. Home Care Settings
13.3.3. Others
13.4. Market Value Forecast by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Top Players Operating in the Market
14.2. Market Share/Heat Map Analysis of Product, by Company, 2021
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. Koninklijke Philips N.V.
14.4.1.1. Company Overview
14.4.1.2. Financial Overview
14.4.1.3. Product Portfolio
14.4.1.4. Business Strategies
14.4.2. Medtronic plc
14.4.2.1 Company Overview
14.4.2.2. Financial Overview
14.4.2.3. Product Portfolio
14.4.2.4. Business Strategies
14.4.3. Compumedics Limited
14.4.3.1. Company Overview
14.4.3.2. Financial Overview
14.4.3.3. Product Portfolio
14.4.3.4. Business Strategies
14.4.4. Natus Medical Incorporated
14.4.4.1. Company Overview
14.4.4.2. Financial Overview
14.4.4.3. Product Portfolio
14.4.4.4. Business Strategies
14.4.5. Empatica, Inc.
14.4.5.1. Company Overview
14.4.5.2. Product Portfolio
14.4.5.3. Business Strategies
14.4.6. PulseGuard International Ltd.
14.4.6.1. Company Overview
14.4.6.2. Product Portfolio
14.4.6.3. Business Strategies
14.4.7. Masimo
14.4.7.1. Company Overview
14.4.7.2. Financial Overview
14.4.7.3. Product Portfolio
14.4.7.4. Business Strategies

List of Tables

Table 01: Product Details and Technology

Table 02: Wrist-worn sensors

Table 03: Bed monitors

Table 04: Bed Monitors & Video Monitor

Table 05: Epilepsy Prevalence Data

Table 06: Approximate Volume Data for Epilepsy Devices (2021)

Table 07: Epilepsy Biomarkers

Table 08: Global Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Global Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 10: Global Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 11: North America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 12: North America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 13: North America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 14: Europe Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 15: Europe Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 16: Europe Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Asia Pacific Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 18: Asia Pacific Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Asia Pacific Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 20: Latin America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Latin America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 22: Latin America Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 23: MEA Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: MEA Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 25: MEA Epilepsy Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031